Presbyopia 发表于 2025-3-23 10:26:02

Submitted on: 23 December 2005.
Revised on: 01 April 2006.
Accepted on: 15 May 2006.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

infelicitous 发表于 2025-3-23 15:06:08

http://reply.papertrans.cn/1/96/9571/9571-12.png

破译 发表于 2025-3-23 19:09:35

Submitted on: 26 May 1999.
Revised on: 18 September 1999.
Accepted on: 09 November 1999.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

amygdala 发表于 2025-3-24 02:05:27

http://reply.papertrans.cn/1/96/9571/9571-14.png

TRUST 发表于 2025-3-24 06:19:59

Submitted on: 09 February 1999.
Revised on: 12 April 1999.
Accepted on: 26 May 1999.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

DEFT 发表于 2025-3-24 09:59:16

http://reply.papertrans.cn/1/96/9571/9571-16.png

GLUT 发表于 2025-3-24 13:35:48

http://reply.papertrans.cn/1/96/9571/9571-17.png

amygdala 发表于 2025-3-24 16:14:02

Submitted on: 09 October 2012.
Revised on: 30 January 2013.
Accepted on: 15 February 2013.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

Ergots 发表于 2025-3-24 21:28:38

Submitted on: 02 October 2021.
Revised on: 22 December 2021.
Accepted on: 12 February 2022.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

characteristic 发表于 2025-3-24 23:40:27

http://reply.papertrans.cn/1/96/9571/9571-20.png
页: 1 [2] 3 4
查看完整版本: SSCI期刊Expert Review of Pharmacoeconomics & Outcomes Research 2024/2025影响因子:1.856 (EXPERT REV PHARM OUT) (1473-7167). (H